Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clínic de Neurociències, Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
Mov Disord. 2009;24 Suppl 2:S656-64. doi: 10.1002/mds.22672.
Pathological and neuroimaging studies have shown that in Parkinson's disease (PD) there is a "subclinical" or "premotor" period during which dopaminergic neurons in the substantia nigra (SN) degenerate but typical motor symptoms have not yet developed. Post-mortem studies based on nigral cell counts and evaluating dopamine levels in the striata, and imaging studies assessing the nigrostriatal pathway in vivo, have estimated that this time period could last 3 to 6 years. In addition, emerging evidence indicates that the neuropathological process of PD does not start in the SN but more likely elsewhere in the nervous system: in the lower brainstem and the olfactory bulb, or even more distant from the SN, such as in the peripheral autonomic nervous system. Patients with PD frequently can present non-motor symptoms, such as hyposmia or constipation, years before the development of classical motor signs. The physiopathology of these "premotor" symptoms, though still unclear, is currently thought to be related to early involvement by the pathological process underlying PD of non-dopaminergic lower brainstem structures or autonomic plexuses. However, the answer to the question "when does PD start" remains uncertain. Here, we review clinical, pathological, and neuroimaging data related to the onset of the pathological process of PD, and propose that its onset is non-motor and that non-motor symptoms could begin in many instances 10 and 20 years before onset of motor symptoms. The variable course of the disorder once the motor symptoms develop, suggests that the start and progression of premotor PD is also highly variable and given the heterogeneous nature of PD, may differ depending on the cause/s of the syndrome. When and where the neuropathological process develops in PD remains uncertain.
病理学和神经影像学研究表明,在帕金森病(PD)中,存在一个“亚临床”或“前驱”期,在此期间,黑质(SN)中的多巴胺能神经元退化,但尚未出现典型的运动症状。基于 SN 细胞计数和评估纹状体中多巴胺水平的尸检研究,以及评估活体黑质纹状体通路的影像学研究,估计这段时间可能持续 3 到 6 年。此外,新出现的证据表明,PD 的神经病理学过程并非从 SN 开始,而更可能从神经系统的其他部位开始:在下脑桥和嗅球,甚至更远的 SN,如周围自主神经系统。PD 患者经常在出现典型运动症状之前数年出现非运动症状,如嗅觉减退或便秘。这些“前驱”症状的病理生理学虽然仍不清楚,但目前认为与 PD 病理过程早期累及非多巴胺能下脑桥结构或自主神经丛有关。然而,“PD 何时开始”的问题仍然没有答案。在这里,我们回顾与 PD 病理过程开始相关的临床、病理和神经影像学数据,并提出其开始是非运动性的,并且在许多情况下,非运动症状可能在运动症状出现前 10 年和 20 年开始。一旦出现运动症状,该疾病的病程变化提示前驱 PD 的开始和进展也是高度可变的,并且鉴于 PD 的异质性,可能因综合征的原因而异。PD 中神经病理学过程在何处以及何时发展仍不确定。